Clinical studies have demonstrated a significant reduction in the concentration of PYY and the number of PYY cells in the colons of patients with IBS, potentially contributing to intestinal motility disorders and visceral hypersensitivity in these individuals [137]. The gene discussed is PYY; the disease is intestinal motility disease.